Heterogeneity of the efficacy of the 23-valent pneumococcal polysaccharide vaccine caused by various underlying conditions of chronic pulmonary disease in older patients: prospective cohort study

OBJECTIVE: To determine the ideal conditions for use of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in older outpatients with chronic pulmonary diseases. DESIGN: Prospective cohort study. PARTICIPANTS: 1378 outpatients with chronic pulmonary diseases ≥60 years of age. INTERVENTION: Par...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Satoshi, Watanuki, Yuji, Kaneko, Tetsuji, Sato, Takashi, Miyazawa, Naoki, Kaneko, Takeshi, Ishigatsubo, Yoshiaki, Morita, Satoshi, Natsumeda, Yutaka, Mizushima, Shunsaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2011
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191416/
https://www.ncbi.nlm.nih.gov/pubmed/22021764
http://dx.doi.org/10.1136/bmjopen-2011-000105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191416/
https://www.ncbi.nlm.nih.gov/pubmed/22021764
http://dx.doi.org/10.1136/bmjopen-2011-000105

Ejemplares similares